Literature DB >> 15470432

Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus.

Darwyn Kobasa1, Ayato Takada, Kyoko Shinya, Masato Hatta, Peter Halfmann, Steven Theriault, Hiroshi Suzuki, Hidekazu Nishimura, Keiko Mitamura, Norio Sugaya, Taichi Usui, Takeomi Murata, Yasuko Maeda, Shinji Watanabe, M Suresh, Takashi Suzuki, Yasuo Suzuki, Heinz Feldmann, Yoshihiro Kawaoka.   

Abstract

The 'Spanish' influenza pandemic of 1918-19 was the most devastating outbreak of infectious disease in recorded history. At least 20 million people died from their illness, which was characterized by an unusually severe and rapid clinical course. The complete sequencing of several genes of the 1918 influenza virus has made it possible to study the functions of the proteins encoded by these genes in viruses generated by reverse genetics, a technique that permits the generation of infectious viruses entirely from cloned complementary DNA. Thus, to identify properties of the 1918 pandemic influenza A strain that might be related to its extraordinary virulence, viruses were produced containing the viral haemagglutinin (HA) and neuraminidase (NA) genes of the 1918 strain. The HA of this strain supports the pathogenicity of a mouse-adapted virus in this animal. Here we demonstrate that the HA of the 1918 virus confers enhanced pathogenicity in mice to recent human viruses that are otherwise non-pathogenic in this host. Moreover, these highly virulent recombinant viruses expressing the 1918 viral HA could infect the entire lung and induce high levels of macrophage-derived chemokines and cytokines, which resulted in infiltration of inflammatory cells and severe haemorrhage, hallmarks of the illness produced during the original pandemic.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15470432     DOI: 10.1038/nature02951

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  187 in total

1.  Autopsy series of 68 cases dying before and during the 1918 influenza pandemic peak.

Authors:  Zong-Mei Sheng; Daniel S Chertow; Xavier Ambroggio; Sherman McCall; Ronald M Przygodzki; Robert E Cunningham; Olga A Maximova; John C Kash; David M Morens; Jeffery K Taubenberger
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

2.  Enhanced growth of influenza vaccine seed viruses in vero cells mediated by broadening the optimal pH range for virus membrane fusion.

Authors:  Shin Murakami; Taisuke Horimoto; Mutsumi Ito; Ryo Takano; Hiroaki Katsura; Masayuki Shimojima; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

3.  Critical role of airway macrophages in modulating disease severity during influenza virus infection of mice.

Authors:  Michelle D Tate; Danielle L Pickett; Nico van Rooijen; Andrew G Brooks; Patrick C Reading
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

4.  Mapping the pulmonary environment of animals protected from virulent H1N1 influenza infection using the TLR-2 agonist Pam₂Cys.

Authors:  Edin J Mifsud; Amabel C L Tan; Patrick C Reading; David C Jackson
Journal:  Immunol Cell Biol       Date:  2015-08-14       Impact factor: 5.126

5.  Biopolymer encapsulated live influenza virus as a universal CD8+ T cell vaccine against influenza virus.

Authors:  Alina C Boesteanu; Nadarajan S Babu; Margaret Wheatley; Elisabeth S Papazoglou; Peter D Katsikis
Journal:  Vaccine       Date:  2010-10-27       Impact factor: 3.641

Review 6.  The threat of avian influenza a (H5N1): part II: Clues to pathogenicity and pathology.

Authors:  Jindrich Cinatl; Martin Michaelis; Hans W Doerr
Journal:  Med Microbiol Immunol       Date:  2007-04-04       Impact factor: 3.402

Review 7.  Pathogenicity of highly pathogenic avian influenza virus in mammals.

Authors:  Emmie de Wit; Yoshihiro Kawaoka; Menno D de Jong; Ron A M Fouchier
Journal:  Vaccine       Date:  2008-09-12       Impact factor: 3.641

8.  A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity.

Authors:  Laurel Glaser; James Stevens; Dmitriy Zamarin; Ian A Wilson; Adolfo García-Sastre; Terrence M Tumpey; Christopher F Basler; Jeffery K Taubenberger; Peter Palese
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  Acquisition of a polybasic hemagglutinin cleavage site by a low-pathogenic avian influenza virus is not sufficient for immediate transformation into a highly pathogenic strain.

Authors:  Olga Stech; Jutta Veits; Siegfried Weber; Daniela Deckers; Diana Schröer; Thomas W Vahlenkamp; Angele Breithaupt; Jens Teifke; Thomas C Mettenleiter; Jürgen Stech
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

10.  The PA-gene-mediated lethal dissemination and excessive innate immune response contribute to the high virulence of H5N1 avian influenza virus in mice.

Authors:  Jiao Hu; Zenglei Hu; Qingqing Song; Min Gu; Xiaowen Liu; Xiaoquan Wang; Shunlin Hu; Chaoyang Chen; Huimou Liu; Wenbo Liu; Sujuan Chen; Daxin Peng; Xiufan Liu
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.